First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer
Clinical trial NCT03451370 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03451370
- Sponsor
- Istituto Oncologico Veneto IRCCS
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2017-11-01
- Primary completion
- 2027-02-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.